Home LiteratureArticle Details
PMID: 7933076 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.

Journal of virology ·Vol. 68 ·No. 11 ·1994-11-00 ·Pages 6947-58

Laux G, Dugrillon F, Eckert C, Adam B, Zimber-Strobl U, Bornkamm GW

Abstract

Epstein-Barr virus (EBV) transforms resting B cells in vitro very efficiently. The nuclear viral protein EBV nuclear antigen 2 (EBNA2) is absolutely required for this process and also acts as a transcriptional activator of cellular and viral genes. As shown previously, EBNA2 transactivates the promoters of the viral latent membrane proteins. It interacts indirectly with an EBNA2-responsive cis element of the terminal protein 1 (TP1) promoter. To identify the sequences mediating EBNA2 transactivation of the bidirectional promoter region driving expression of the latent membrane proteins LMP and TP2 in opposite directions, we assayed the effects of EBNA2 on the activities of promoter deletion and site-directed mutants of TP2 and LMP promoter luciferase reporter gene constructs by cotransfections into EBNA2-negative Burkitt's lymphoma cells. We were able to delineate an 80-bp EBNA2-responsive region (EBNA2RE) between -232 and -152 relative to the LMP RNA start site which could also mediate EBNA2-dependent activation on a heterologous promoter. Sequences of 20 and 32 bp located at the 5' and 3' ends, respectively, of the EBNA2RE were both essential for EBNA2 responsiveness. Full transactivation of the LMP and TP2 promoters seemed to require 20 bp of 5' adjacent sequences in addition to the 80-bp element. Electrophoretic mobility shift assays revealed specific protein-DNA complexes formed at the EBNA2RE. Oligonucleotides from -181 to -152 and -166 to -132 relative to the LMP RNA start site visualized one B-cell and one B-cell-plus-HL60-specific retarded protein-DNA complex, respectively. Additionally, an oligonucleotide from -253 to -210 revealed two specific protein-DNA complexes with nuclear extracts from different B and non-B cells, suggesting also the binding of ubiquitously expressed proteins on the EBNA2RE. Thus, these experiments defined a 80-bp cis element sufficient for conferring EBNA2 inducibility and demonstrated specific interactions of cellular proteins at DNA sequences within the EBNA2RE, which are critical for transactivation by EBNA2.

MeSH Terms
Antigens, Viral/genetics,physiology Base Sequence DNA-Binding Proteins/analysis,physiology Epstein-Barr Virus Nuclear Antigens Genes, Viral Herpesvirus 4, Human/genetics,immunology Humans Molecular Sequence Data Organ Specificity Promoter Regions, Genetic Viral Matrix Proteins/genetics
Chemicals
Antigens, Viral DNA-Binding Proteins EBV-associated membrane antigen, Epstein-Barr virus Epstein-Barr Virus Nuclear Antigens Viral Matrix Proteins
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Laux G
Institut für Klinische Molekularbiologie und Tumorgenetik, GSF-Forschungszentrum für Umwelt und Gesundheit GmbH, München, Germany.
Dugrillon F
Eckert C
Adam B
Zimber-Strobl U
Bornkamm G W
References (62)
62 references, click to expand
  1. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    J Virol. 1990 May;64(5):2309-18 PMID: 2157887
  2. Epstein-Barr virus RNA. V. Viral RNA in a restringently infected, growth-transformed cell line.
    J Virol. 1980 Nov;36(2):506-18 PMID: 6253674
  3. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.
    J Virol. 1990 Jul;64(7):3407-16 PMID: 2352328
  4. A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein.
    Cell. 1990 Jun 29;61(7):1217-24 PMID: 2142019
  5. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.
    Proc Natl Acad Sci U S A. 1990 Oct;87(19):7390-4 PMID: 2170976
  6. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
    J Virol. 1991 Jan;65(1):415-23 PMID: 1845900
  7. Variable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.
    J Virol. 1991 Mar;65(3):1558-67 PMID: 1847471
  8. Early events in Epstein-Barr virus infection of human B lymphocytes.
    Virology. 1991 Apr;181(2):595-608 PMID: 1849678
  9. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.
    J Virol. 1991 May;65(5):2164-9 PMID: 1850003
  10. Epstein-Barr virus nuclear protein 2 mutations define essential domains for transformation and transactivation.
    J Virol. 1991 May;65(5):2545-54 PMID: 1850028
  11. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection.
    Proc Natl Acad Sci U S A. 1991 May 1;88(9):3942-6 PMID: 1850841
  12. Biochemical characterization of Epstein-Barr virus nuclear antigen 2A.
    J Virol. 1991 Jul;65(7):3779-88 PMID: 1645792
  13. The E2F transcription factor is a cellular target for the RB protein.
    Cell. 1991 Jun 14;65(6):1053-61 PMID: 1828392
  14. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A.
    Cell. 1991 Jun 28;65(7):1243-53 PMID: 1829647
  15. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element.
    J Virol. 1991 Aug;65(8):4101-6 PMID: 1649318
  16. An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator.
    J Virol. 1991 Nov;65(11):5880-5 PMID: 1656076
  17. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
    J Virol. 1991 Dec;65(12):6765-71 PMID: 1658373
  18. Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes.
    J Virol. 1992 Jan;66(1):496-504 PMID: 1309259
  19. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
    J Virol. 1992 May;66(5):2689-97 PMID: 1313894
  20. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter.
    J Virol. 1992 May;66(5):2846-52 PMID: 1313905
  21. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma.
    J Virol. 1992 May;66(5):3257-62 PMID: 1313931
  22. Phosphorylation of the Epstein-Barr virus nuclear antigen 2.
    Biochem Biophys Res Commun. 1992 Aug 14;186(3):1694-701 PMID: 1324672
  23. Epstein-Barr virus (EBV) nuclear-antigen-2-induced up-regulation of CD21 and CD23 molecules is dependent on a permissive cellular context.
    Int J Cancer. 1993 Jan 2;53(1):153-60 PMID: 8416201
  24. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter.
    EMBO J. 1993 Jan;12(1):167-75 PMID: 8381349
  25. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation.
    J Virol. 1993 Apr;67(4):2014-25 PMID: 8445720
  26. Expression of the Epstein-Barr virus (EBV) latent membrane protein is tightly regulated, independently of EB nuclear antigen 2 and of EBV integration or copy number.
    Virus Res. 1993 Jan;27(1):55-69 PMID: 8383394
  27. Identification of the Epstein-Barr virus nuclear antigen 2 transactivation domain.
    Biochem Biophys Res Commun. 1993 Feb 26;191(1):196-200 PMID: 8383488
  28. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
    Virology. 1993 Apr;193(2):774-85 PMID: 8384755
  29. Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences.
    Virology. 1993 Jul;195(1):71-80 PMID: 8391188
  30. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
    Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9150-4 PMID: 8415670
  31. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.
    Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 PMID: 6828386
  32. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.
    J Virol. 1984 Aug;51(2):411-9 PMID: 6086953
  33. DNA sequence and expression of the B95-8 Epstein-Barr virus genome.
    Nature. 1984 Jul 19-25;310(5974):207-11 PMID: 6087149
  34. Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8.
    J Virol. 1985 Feb;53(2):528-35 PMID: 2982035
  35. The use of lymphomatous and lymphoblastoid cell lines in the study of Burkitt's lymphoma.
    IARC Sci Publ. 1985;(60):309-18 PMID: 3934070
  36. Induction of Epstein-Barr virus nuclear antigens.
    J Virol. 1986 Jun;58(3):988-90 PMID: 3084809
  37. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Proc Natl Acad Sci U S A. 1987 May;84(10):3452-6 PMID: 3033649
  38. OVEC, a versatile system to study transcription in mammalian cells and cell-free extracts.
    Nucleic Acids Res. 1987 Sep 11;15(17):6787-98 PMID: 3658668
  39. Epstein-Barr virus (EBV) induces expression of B-cell activation markers on in vitro infection of EBV-negative B-lymphoma cells.
    Proc Natl Acad Sci U S A. 1987 Nov;84(22):8060-4 PMID: 2825176
  40. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line.
    J Cell Biol. 1988 Mar;106(3):761-71 PMID: 2450098
  41. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
    J Gen Virol. 1988 May;69 ( Pt 5):1051-65 PMID: 2836550
  42. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.
    Int J Cancer. 1988 Sep 15;42(3):329-38 PMID: 2843473
  43. Two related Epstein-Barr virus membrane proteins are encoded by separate genes.
    J Virol. 1989 Feb;63(2):933-7 PMID: 2536113
  44. Influence of Burkitt's lymphoma and primary B cells on latent gene expression by the nonimmortalizing P3J-HR-1 strain of Epstein-Barr virus.
    J Virol. 1989 Apr;63(4):1531-9 PMID: 2538644
  45. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.
    J Gen Virol. 1989 Jul;70 ( Pt 7):1755-64 PMID: 2544663
  46. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
    Nature. 1989 Aug 3;340(6232):393-7 PMID: 2547164
  47. The terminal protein gene 2 of Epstein-Barr virus is transcribed from a bidirectional latent promoter region.
    J Gen Virol. 1989 Nov;70 ( Pt 11):3079-84 PMID: 2555438
  48. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
    Proc Natl Acad Sci U S A. 1989 Dec;86(23):9558-62 PMID: 2556717
  49. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
    J Virol. 1990 Mar;64(3):1002-13 PMID: 2154588
  50. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene.
    Cell. 1990 Apr 6;61(1):113-24 PMID: 2180582
  51. cis-acting regulatory elements near the Epstein-Barr virus latent-infection membrane protein transcriptional start site.
    J Virol. 1990 Apr;64(4):1855-8 PMID: 2157069
  52. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
    J Virol. 1990 May;64(5):2126-34 PMID: 2157875
  53. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
    Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9237-41 PMID: 8415684
  54. Clonality, expression and methylation patterns of the Epstein-Barr virus genomes in lethal midline granulomas classified as peripheral angiocentric T cell lymphomas.
    J Gen Virol. 1994 Jan;75 ( Pt 1):77-84 PMID: 8113742
  55. Recognition sequence of a highly conserved DNA binding protein RBP-J kappa.
    Nucleic Acids Res. 1994 Mar 25;22(6):965-71 PMID: 8152928
  56. A STUDY OF MALIGNANT TUMOURS IN NIGERIA BY SHORT-TERM TISSUE CULTURE.
    J Clin Pathol. 1965 May;18:261-73 PMID: 14304234
  57. Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.
    J Virol. 1967 Oct;1(5):1045-51 PMID: 4912237
  58. Differences between laboratory strains of Epstein-Barr virus based on immortalization, abortive infection, and interference.
    Proc Natl Acad Sci U S A. 1974 Oct;71(10):4006-10 PMID: 4372601
  59. Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75).
    Int J Cancer. 1977 Jan;19(1):27-33 PMID: 188769
  60. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture.
    Nature. 1977 Nov 24;270(5635):347-9 PMID: 271272
  61. Biological and biochemical observations on isolates of EB virus from the malignant epithelial cells of two nasopharyngeal carcinomas.
    Int J Cancer. 1979 Sep 15;24(3):294-302 PMID: 226484
  62. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization.
    J Virol. 1990 Jun;64(6):2530-6 PMID: 2159528
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1994-11-00
Pages
6947-58
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC237131
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]